Treatment of a Large Cohort of Childhood Chronic Noninfectious Uveitis in a Multicentric Large Study: Adalimumab Versus Methotrexate as First‐Line Therapy
Adalimumab shows promise as a potential first-line therapy for cCIU, particularly for posterior segment uveitis. Although effective in anterior uveitis, methotrexate leads children to relapse earlier than adalimumab.
Authors
- Ilaria Maccora (ORCID: https://orcid.org/0000-0001-6418-3254)
- G. Simonini
- Cinzia de Libero
- Athimalaipet V. Ramanan
- Giulia Carreras
Institutions
- Bristol Royal Hospital for Children (GB)
- University of Bristol (GB)
- Bristol Eye Hospital (GB)
- Meyer Children's Hospital (IT)
- University of Florence (IT)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2026-02-10
- DOI
- https://doi.org/10.1002/art.70090
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Swedish Orphan Biovitrum